Safety and efficacy of trabectedin when administered in the inpatient versus outpatient setting: Clinical considerations for outpatient administration of trabectedin期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

Safety and efficacy of trabectedin when administered in the inpatient versus outpatient setting: Clinical considerations for outpatient administration of trabectedin

Authors:	Robin L. Jones MD Robert G. Maki MD PhD Shreyaskumar R. Patel MD George Wang MS Tracy A. McGowan MD Waleed S. Shalaby MD PhD Roland E. Knoblauch MD Margaret von Mehren MD George D. Demetri MD

Affiliation:	1. Sarcoma Unit, Institute of Cancer Research, Royal Marsden Hospital, London, United Kingdom;2. Medical Oncology and Hematology, Monter Cancer Center, Northwell Health, New Hyde Park, New York;3. Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas;4. Clinical Oncology, Janssen Research & Development LLC, Raritan, New Jersey;5. Medical Group Oncology, Janssen Scientific Affairs LLC, Horsham, Pennsylvania;6. Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania;7. Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts Ludwig Center, Dana-Farber/Harvard Cancer Center, Boston, Massachusetts

Abstract:

Keywords:	extravasation inpatients leiomyosarcoma liposarcoma outpatients soft-tissue sarcoma trabectedin